Karen Flynn Insider Trading $WST WEST PHARMACEUTICAL SERVICES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Flynn. Karen Flynn is President, America's Region in WEST PHARMACEUTICAL SERVICES INC ($WST) and President, Pharma Pckg Systems in WEST PHARMACEUTICAL SERVICES INC ($WST) and Sr VP & Chief Commercial Offic in WEST PHARMACEUTICAL SERVICES INC ($WST) and Director in Recro Pharma, Inc. ($REPH) and Pres. Biologics & CCO in Catalent, Inc. ($CTLT).
Karen Flynn in WEST PHARMACEUTICAL SERVICES INC
Trading Symbol: WSTIndustry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of Karen Flynn: Sr VP & Chief Commercial Offic, President, Pharma Pckg Systems, President, America's Region
Holdings: 23,692 shares
Current Value: $2,029,457
Latest Transaction: Feb 21 2019
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Karen Flynn in WEST PHARMACEUTICAL SERVICES INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CTLT, REPH, WST
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 21 2019 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Option Exercise | A | 102.51 | 14,280 | 1,463,843 | 14,280 | |
Feb 21 2019 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 102.51 | 2,099 | 215,168 | 23,692 | 21.6 K to 23.7 K (+9.72 %) |
Aug 09 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Option Exercise | M | 21.22 | 9,458 | 200,699 | 0 | |
Aug 09 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Option Exercise | M | 25.15 | 11,000 | 276,595 | 20,982 | |
Aug 09 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Sell | S | 116.23 | 20,458 | 2,377,833 | 21,593 | 42.1 K to 21.6 K (-48.65 %) |
Aug 09 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Buy | M | 25.15 | 11,000 | 276,595 | 42,051 | 31.1 K to 42.1 K (+35.43 %) |
Aug 09 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Buy | M | 21.22 | 9,458 | 200,699 | 31,051 | 21.6 K to 31.1 K (+43.80 %) |
Feb 22 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Option Exercise | A | 89.64 | 17,544 | 1,572,644 | 17,544 | |
Feb 15 2018 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 93.00 | 3,870 | 359,910 | 21,593 | 17.7 K to 21.6 K (+21.84 %) |
Dec 05 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 99.11 | 7 | 694 | 1,298 | 1.3 K to 1.3 K (+0.54 %) |
Nov 21 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 98.96 | 7 | 693 | 1,290 | 1.3 K to 1.3 K (+0.55 %) |
Nov 07 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 100.95 | 7 | 707 | 1,283 | 1.3 K to 1.3 K (+0.55 %) |
Oct 24 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 93.84 | 8 | 751 | 1,275 | 1.3 K to 1.3 K (+0.63 %) |
Oct 11 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 95.45 | 8 | 764 | 1,267 | 1.3 K to 1.3 K (+0.64 %) |
Sep 25 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 95.21 | 8 | 762 | 1,260 | 1.3 K to 1.3 K (+0.64 %) |
Sep 11 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 91.43 | 8 | 731 | 1,252 | 1.2 K to 1.3 K (+0.64 %) |
Aug 29 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 85.43 | 9 | 769 | 1,244 | 1.2 K to 1.2 K (+0.73 %) |
Aug 14 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 84.93 | 7 | 595 | 1,235 | 1.2 K to 1.2 K (+0.57 %) |
Mar 07 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Payment of Exercise | F | 83.13 | 86 | 7,149 | 17,605 | 17.7 K to 17.6 K (-0.49 %) |
Feb 22 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Option Exercise | A | 83.47 | 8,356 | 697,475 | 27,868 | |
Feb 22 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Option Exercise | A | 83.47 | 19,512 | 1,628,667 | 19,512 | |
Feb 16 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 86.93 | 4,049 | 351,980 | 17,691 | 13.6 K to 17.7 K (+29.68 %) |
Jan 03 2017 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 84.83 | 8 | 679 | 1,222 | 1.2 K to 1.2 K (+0.66 %) |
Dec 19 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 84.63 | 8 | 677 | 1,214 | 1.2 K to 1.2 K (+0.66 %) |
Dec 05 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 80.57 | 9 | 725 | 1,206 | 1.2 K to 1.2 K (+0.75 %) |
Nov 21 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 80.14 | 9 | 721 | 1,197 | 1.2 K to 1.2 K (+0.76 %) |
Nov 07 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 75.39 | 9 | 679 | 1,188 | 1.2 K to 1.2 K (+0.76 %) |
Oct 24 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 71.68 | 10 | 717 | 1,179 | 1.2 K to 1.2 K (+0.86 %) |
Oct 11 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 75.44 | 9 | 679 | 1,168 | 1.2 K to 1.2 K (+0.78 %) |
Sep 26 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 72.55 | 10 | 726 | 1,159 | 1.1 K to 1.2 K (+0.87 %) |
Sep 12 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Grant | A | 80.19 | 9 | 722 | 1,149 | 1.1 K to 1.1 K (+0.79 %) |
Sep 07 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | Sr VP & Chief Comme ... | Sell | S | 83.28 | 14,581 | 1,214,306 | 13,513 | 28.1 K to 13.5 K (-51.90 %) |
Aug 29 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 81.56 | 8 | 652 | 1,140 | 1.1 K to 1.1 K (+0.71 %) |
Aug 15 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 81.00 | 1 | 81 | 1,132 | 1.1 K to 1.1 K (+0.09 %) |
Aug 15 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 81.00 | 1 | 81 | 1,132 | 1.1 K to 1.1 K (+0.09 %) |
Feb 25 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | A | 59.64 | 26,020 | 1,551,833 | 26,020 | |
Feb 25 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 59.64 | 3,914 | 233,431 | 27,966 | 24.1 K to 28 K (+16.27 %) |
Jan 05 2016 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 60.22 | 11 | 662 | 1,112 | 1.1 K to 1.1 K (+1.00 %) |
Dec 22 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 60.62 | 11 | 667 | 1,101 | 1.1 K to 1.1 K (+1.01 %) |
Dec 08 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 62.80 | 10 | 628 | 1,091 | 1.1 K to 1.1 K (+0.93 %) |
Nov 24 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 62.24 | 10 | 622 | 1,080 | 1.1 K to 1.1 K (+0.93 %) |
Nov 12 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | M | 21.34 | 9,458 | 201,834 | 0 | |
Nov 12 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | M | 20.43 | 8,562 | 174,879 | 0 | |
Nov 12 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Sell | S | 63.03 | 18,020 | 1,135,723 | 24,610 | 42.6 K to 24.6 K (-42.27 %) |
Nov 12 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Buy | M | 20.43 | 8,562 | 174,879 | 42,630 | 34.1 K to 42.6 K (+25.13 %) |
Nov 12 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Buy | M | 21.34 | 9,458 | 201,834 | 34,068 | 24.6 K to 34.1 K (+38.43 %) |
Nov 09 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 63.64 | 10 | 636 | 1,070 | 1.1 K to 1.1 K (+0.94 %) |
Oct 27 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 57.02 | 11 | 627 | 1,060 | 1 K to 1.1 K (+1.05 %) |
Oct 22 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | A | 55.42 | 2,500 | 138,550 | 2,500 | |
Oct 14 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 54.89 | 12 | 659 | 1,049 | 1 K to 1 K (+1.16 %) |
Sep 29 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 55.66 | 12 | 668 | 1,037 | 1 K to 1 K (+1.17 %) |
Sep 01 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 56.86 | 10 | 569 | 1,025 | 1 K to 1 K (+0.99 %) |
May 26 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | M | 16.05 | 3,091 | 49,595 | 0 | |
May 26 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Sell | S | 55.24 | 3,091 | 170,737 | 24,610 | 27.7 K to 24.6 K (-11.16 %) |
May 26 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Buy | M | 16.05 | 3,091 | 49,595 | 27,701 | 24.6 K to 27.7 K (+12.56 %) |
May 19 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | M | 16.05 | 1,909 | 30,630 | 3,091 | |
May 19 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Sell | S | 55.00 | 1,909 | 104,995 | 24,610 | 26.5 K to 24.6 K (-7.20 %) |
May 19 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Buy | M | 16.05 | 1,909 | 30,630 | 26,519 | 24.6 K to 26.5 K (+7.76 %) |
Feb 25 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Option Exercise | A | 54.14 | 29,440 | 1,593,882 | 29,440 | |
Feb 24 2015 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, Pharma P ... | Grant | A | 51.53 | 9,098 | 468,820 | 23,719 | 14.6 K to 23.7 K (+62.23 %) |
Dec 10 2012 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, America' ... | Grant | A | 54.71 | 3 | 164 | 3 | 0 to 3 |
Jul 27 2012 | WST | WEST PHARMACEUTICA ... | Flynn Karen | President, America' ... | Option Exercise | A | 50.29 | 15,991 | 804,187 | 15,991 |
Page: 1